The store will not work correctly when cookies are disabled.
(E)-3-(2-hydroxyphenyl)-1-(5-isobutylpyrazin-2-yl)prop-2-en-1-one
ID: ALA2288842
PubChem CID: 6474711
Max Phase: Preclinical
Molecular Formula: C17H18N2O2
Molecular Weight: 282.34
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: CC(C)Cc1cnc(C(=O)/C=C/c2ccccc2O)cn1
Standard InChI: InChI=1S/C17H18N2O2/c1-12(2)9-14-10-19-15(11-18-14)17(21)8-7-13-5-3-4-6-16(13)20/h3-8,10-12,20H,9H2,1-2H3/b8-7+
Standard InChI Key: VGSZTNZKIRNRBO-BQYQJAHWSA-N
Molfile:
RDKit 2D
21 22 0 0 0 0 0 0 0 0999 V2000
18.7362 -6.4302 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.7351 -7.2497 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.4431 -7.6587 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
20.1528 -7.2492 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.1499 -6.4266 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.4413 -6.0213 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
20.8561 -6.0153 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.5653 -6.4213 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.8530 -5.1981 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
22.2715 -6.0100 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.9807 -6.4159 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.9807 -7.2320 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.6891 -7.6378 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.3963 -7.2265 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.3906 -6.4051 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.6816 -6.0030 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.0270 -7.6578 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.0264 -8.4749 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.3183 -8.8830 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.7338 -8.8841 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.6748 -5.1858 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
5 7 1 0
7 8 1 0
7 9 2 0
8 10 2 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 11 1 0
2 17 1 0
17 18 1 0
18 19 1 0
18 20 1 0
16 21 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 282.34 | Molecular Weight (Monoisotopic): 282.1368 | AlogP: 3.28 | #Rotatable Bonds: 5 |
Polar Surface Area: 63.08 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 8.85 | CX Basic pKa: ┄ | CX LogP: 3.10 | CX LogD: 3.09 |
Aromatic Rings: 2 | Heavy Atoms: 21 | QED Weighted: 0.67 | Np Likeness Score: -0.18 |
References
1. Opletalová V, Hartl J, Patel A, Palát K, Buchta V.. (2002) Ring substituted 3-phenyl-1-(2-pyrazinyl)-2-propen-1-ones as potential photosynthesis-inhibiting, antifungal and antimycobacterial agents., 57 (2): [PMID:11902656] [10.1016/s0014-827x(01)01187-9] |